Exchange Agreements in the Biotechnology Industry

544 Contracts & Agreements

Browse by Company

89bio, Inc. (1 contract)
ABEONA THERAPEUTICS INC. (2)
ACCELERON PHARMA INC (6)
Achaogen, Inc. (2)
Acorda Therapeutics (1)
Actinium Pharmaceuticals, Inc. (2)
Adhera Therapeutics, Inc. (1)
ADiTx Therapeutics, Inc. (6)
ADMA BIOLOGICS, INC. (9)
Advaxis, Inc. (7)
Aeglea BioTherapeutics, Inc. (1)
AGENUS INC (10)
AgeX Therapeutics, Inc. (1)
AGIOS PHARMACEUTICALS INC (5)
AILERON THERAPEUTICS INC (3)
Aimmune Therapeutics, Inc. (2)
Akebia Therapeutics, Inc. (1)
ALBIREO PHARMA, INC. (2)
Allarity Therapeutics, Inc. (1)
Alliqua BioMedical, Inc. (2)
Allogene Therapeutics, Inc. (1)
ALNYLAM PHARMACEUTICALS, INC. (2)
ALPINE IMMUNE SCIENCES, INC. (1)
Altimmune, Inc. (5)
Amgen Inc. (5)
AMICUS THERAPEUTICS, INC. (1)
AmpliPhi Biosciences Corp (4)
ANAVEX LIFE SCIENCES CORP. (1)
Apellis Pharmaceuticals, Inc. (6)
Applied Therapeutics Inc. (1)
AQUINOX PHARMACEUTICALS, INC (2)
Arbutus Biopharma Corp (5)
ARENA PHARMACEUTICALS INC (1)
ARROWHEAD PHARMACEUTICALS, INC. (7)
Athenex, Inc. (1)
aTYR PHARMA INC (1)
AVEO PHARMACEUTICALS INC (2)
BeiGene, Ltd. (9)
BICYCLE THERAPEUTICS Ltd (2)
BioCardia, Inc. (1)
BIOCRYST PHARMACEUTICALS INC (2)
Biohaven Pharmaceutical Holding Co Ltd. (1)
BioNexus Gene Lab Coporation (2)
BioRestorative Therapies, Inc. (8)
BIOTIME INC (2)
BIOXYTRAN, INC (1)
Blue Water Vaccines Inc. (1)
BRAINSTORM CELL THERAPEUTICS INC. (2)
CareDx, Inc. (1)
CASI Pharmaceuticals, Inc. (4)
CATALYST BIOSCIENCES, INC. (1)
Cell Source, Inc. (2)
Celldex Therapeutics, Inc. (2)
Cellectar Biosciences, Inc. (3)
Celsion CORP (1)
CEREBAIN BIOTECH CORP. (1)
Chanticleer Holdings, Inc. (4)
ChemoCentryx, Inc. (2)
Cidara Therapeutics, Inc. (1)
Clovis Oncology, Inc. (2)
Conatus Pharmaceuticals Inc. (2)
Corvus Pharmaceuticals, Inc. (1)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (1)
CTI BIOPHARMA CORP (6)
Cullinan Oncology, LLC (1)
CURIS INC (9)
Cyclacel Pharmaceuticals, Inc. (2)
Day One Biopharmaceuticals Holding Co LLC (1)
DelMar Pharmaceuticals, Inc. (2)
Dermavant Sciences Ltd (1)
Digital Development Partners, Inc. (6)
DYNAVAX TECHNOLOGIES CORP (1)
Edge Therapeutics, Inc. (2)
Emergent BioSolutions Inc. (5)
Enanta Pharmaceuticals, Inc. (7)
ENDONOVO THERAPEUTICS, INC. (2)
Enochian Biosciences Inc (1)
ENZOLYTICS INC (1)
ENZON PHARMACEUTICALS, INC. (1)
Epizyme, Inc. (2)
Esperion Therapeutics, Inc. (1)
EXICURE, INC. (1)
Fibrocell Science, Inc. (1)
Fortress Biotech, Inc. (2)
Gain Therapeutics, Inc. (1)
GALECTIN THERAPEUTICS INC (1)
Gene Biotherapeutics, Inc. (2)
GENOCEA BIOSCIENCES, INC. (8)
GeoVax Labs, Inc. (2)
GERON CORP (1)
Greater Cannabis Company, Inc. (3)
GT Biopharma, Inc. (3)
HEAT BIOLOGICS, INC. (2)
HedgePath Pharmaceuticals, Inc. (2)
HERON THERAPEUTICS, INC. (1)
HISTOGENICS CORP (1)
HST Global, Inc. (4)
iBio, Inc. (1)
IMMUNE PHARMACEUTICALS INC (2)
Immune Therapeutics, Inc. (2)
ImmunoCellular Therapeutics, Ltd. (4)
IMMUNOGEN INC (3)
IMMUNOMEDICS INC (2)
INFINITY PHARMACEUTICALS, INC. (4)
INOVIO PHARMACEUTICALS, INC. (1)
INSMED Inc (3)
Inspyr Therapeutics, Inc. (2)
INTERCEPT PHARMACEUTICALS, INC. (6)
International Stem Cell CORP (3)
Invitae Corp (2)
IOVANCE BIOTHERAPEUTICS, INC. (8)
Kadmon Holdings, Inc. (1)
Karyopharm Therapeutics Inc. (1)
Kindred Biosciences, Inc. (1)
Kiromic Biopharma, Inc. (6)
LA JOLLA PHARMACEUTICAL CO (1)
Ligand Pharmaceuticals Incorporated (1)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (1)
MACROGENICS INC (14)
MARIZYME INC (6)
MATEON THERAPEUTICS INC (1)
MERRIMACK PHARMACEUTICALS INC (3)
Mersana Therapeutics, Inc. (2)
MiMedx Group, Inc. (2)
MIRAGEN THERAPEUTICS, INC. (2)
Molecular Templates, Inc. (1)
Momenta Pharmaceuticals, Inc. (3)
Monte Rosa Therapeutics, Inc. (2)
NANOVIRICIDES, INC. (3)
NAVIDEA BIOPHARMACEUTICALS, INC. (6)
NextCure, Inc. (8)
NORTHWEST BIOTHERAPEUTICS INC (2)
NOVAVAX INC (13)
Novus Therapeutics, Inc. (5)
NTN BUZZTIME INC (1)
Nuo Therapeutics, Inc. (3)
OncBioMune Pharmaceuticals, Inc (4)
ONCOSEC MEDICAL Inc (1)
OPGEN INC (3)
Ophthotech Corp. (3)
Opko Health, Inc. (3)
ORAGENICS INC (1)
Organicell Regenerative Medicine, Inc. (3)
Organogenesis Holdings Inc. (1)
Orgenesis Inc. (7)
Outlook Therapeutics, Inc. (3)
Ovid Therapeutics Inc. (1)
PDL BIOPHARMA, INC. (7)
PIERIS PHARMACEUTICALS, INC. (4)
POLARITYTE, INC. (6)
PREDICTIVE TECHNOLOGY GROUP, INC. (1)
PREMIER BIOMEDICAL INC (3)
PROGENITY, INC. (4)
ProMIS Neurosciences Inc. (1)
Propanc Biopharma, Inc. (1)
Protagenic Therapeutics, Inc. (2)
Protagonist Therapeutics, Inc (1)
Protalix BioTherapeutics, Inc. (3)
PTC THERAPEUTICS, INC. (3)
RECURSION PHARMACEUTICALS, INC. (4)
Rezolute, Inc. (2)
RITTER PHARMACEUTICALS INC (1)
ROCKET PHARMACEUTICALS, INC. (1)
Sage Therapeutics, Inc. (4)
Sarepta Therapeutics, Inc. (1)
SELECTA BIOSCIENCES INC (1)
SELLAS Life Sciences Group, Inc. (1)
Sesen Bio, Inc. (2)
Social Capital Suvretta Holdings Corp. III (1)
Sorrento Therapeutics, Inc. (2)
Spectrum Pharmaceuticals, Inc. (6)
Spero Therapeutics, Inc. (1)
SPHERIX INC (2)
Spring Bank Pharmaceuticals, Inc. (2)
Stellar Biotechnologies, Inc. (1)
Summit Therapeutics Inc. (1)
Sun BioPharma, Inc. (1)
Syndax Pharmaceuticals Inc (1)
Synthetic Biologics, Inc. (1)
TG THERAPEUTICS, INC. (3)
Tonix Pharmaceuticals Holding Corp. (1)
TYME TECHNOLOGIES, INC. (1)
Unicycive Therapeutics, Inc. (1)
United Therapeutics Corp (1)
Unum Therapeutics Inc. (1)
USA EQUITIES CORP. (1)
VACCINEX, INC. (2)
Vaxart, Inc. (1)
Verastem, Inc. (8)
Vericel Corp (1)
Vertex Pharmaceuticals Inc (4)
VistaGen Therapeutics, Inc. (3)
VITAL THERAPIES INC (1)
VITRO DIAGNOSTICS INC (1)
vTv Therapeutics Inc. (2)
WINDTREE THERAPEUTICS INC (2)
Xenetic Biosciences, Inc. (1)
Xenon Pharmaceuticals Inc. (1)
XOMA Corp (11)
YIELD10 BIOSCIENCE, INC. (3)
ZAFGEN, INC. (2)
Zymeworks Inc. (2)

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

Text Marked By [* * *] Has BeenOmitted Pursuant To A Request For Confidential Treatment And Was Filed Separately With The Securities And Exchange Commission. EXECUTIVE EMPLOYMENT...

Exchange Agreements

IOVANCE BIOTHERAPEUTICS, INC.

Biotechnology

2016

Exchange Agreement, dated as of December 19, 2024, by and among Mersana Therapeutics, Inc. and the holders of the common stock listed on Schedule I attached thereto

Exchange Agreements

Mersana Therapeutics, Inc.

Biotechnology

2024

Debt for Equity Exchange Agreement

Exchange Agreements

EXICURE, INC.

2024

Form of Exchange Agreement dated as of November 1, 2024 between the Company and the holder of the Exchange Notes

Exchange Agreements

Kiromic Biopharma, Inc.

2024

Form of Exchange Agreement dated as of September 27, 2024 between the Company and the holder of the Exchange Securities

Exchange Agreements

Kiromic Biopharma, Inc.

2024

Form of exchange agreement, dated as of September 24, 2024, between Eterna Therapeutics Inc. and the parties thereto

Exchange Agreements

NTN BUZZTIME INC

2024

Form of Note Exchange Agreement, dated August 12, 2024, between the Company and the holders named therein

Exchange Agreements

PROGENITY, INC.

2024

Exchange Agreement dated August 7, 2024

Exchange Agreements

ADiTx Therapeutics, Inc.

2024

Share Exchange Agreement, dated May 24, 2024, by and

Exchange Agreements

Allogene Therapeutics, Inc.

2024

Exchange Agreement dated as of June 21, 2024 between the Company and the Holder

Exchange Agreements

Kiromic Biopharma, Inc.

2024

Debt Exchange Agreement, dated as of May 21, 2024, between Orgenesis Inc. and Yosef Dotan

Exchange Agreements

Orgenesis Inc.

2024

Debt Exchange Agreement, dated as of May 21, 2024, between Orgenesis Inc. and Aharon Lukach

Exchange Agreements

Orgenesis Inc.

2024

Debt Exchange Agreement, dated as of May 21, 2024, between Orgenesis Inc. and Yehuda Nir

Exchange Agreements

Orgenesis Inc.

2024

Exchange Agreement, dated April 23, 2024, by and between the Company and Fairmount Healthcare Fund II L.P

Exchange Agreements

Aeglea BioTherapeutics, Inc.

2024

Form of Exchange Agreement dated as of March 28, 2024 between the Company and the holder of the Exchange Securities

Exchange Agreements

Kiromic Biopharma, Inc.

2024

Form of Exchange Agreement, dated March 21, 2024

Exchange Agreements

Unum Therapeutics Inc.

2024

Form of Exchange Agreement, dated as of March 22, 2024, by and among the Company and the warrantholders party thereto

Exchange Agreements

YIELD10 BIOSCIENCE, INC.

2024

Form of Exchange Agreement, dated as of March 22, 2024, by and among the Company and the warrantholders party thereto

Exchange Agreements

YIELD10 BIOSCIENCE, INC.

2024

Form of Exchange Agreement, dated March 13, 2024, by and between Unicycive Therapeutics, Inc. and the purchasers named therein

Exchange Agreements

Unicycive Therapeutics, Inc.

2024

Form of Securities Exchange Agreement

Exchange Agreements

Rezolute, Inc.

2024

Form of Note Exchange Agreement, dated March 8, 2024, between the Company and the holder named therein

Exchange Agreements

PROGENITY, INC.

2024

Exchange and Termination Agreement, by and between the Company and affiliates of Deerfield Management Company, L.P., effective upon January 24, 2024

Exchange Agreements

WINDTREE THERAPEUTICS INC

2024

Exchange Agreement, dated December 28, 2023 by and between the Company and the holders signatory thereto

Exchange Agreements

ADiTx Therapeutics, Inc.

2024

Exchange Agreement, dated December 22, 2023 by and between the Company and the holders signatory thereto

Exchange Agreements

ADiTx Therapeutics, Inc.

2023

Share Exchange Agreement, dated December 15, 2023, by and among Onconetix, Proteomedix AG, Thomas Meier and the Sellers

Exchange Agreements

Blue Water Vaccines Inc.

2023

Form of Note Exchange Agreement, dated December 18, 2023, between the Company and the holders named therein

Exchange Agreements

PROGENITY, INC.

2023

Share Exchange Agreement between the Company and holders of Series 1 Preferred Shares dated December 4, 2023

Exchange Agreements

ProMIS Neurosciences Inc.

2023

Assignment and Exchange Agreement

Exchange Agreements

Adhera Therapeutics, Inc.

2023

Form of Cancellation and Exchange Agreement between Marizyme, Inc. and the creditor party thereto, dated as of November 20, 2023

Exchange Agreements

MARIZYME INC

2023

Exchange Agreement, dated as of October 12, 2023, between Applied Therapeutics, Inc. and Venrock Healthcare Capital Partners EG, L.P., Venrock Healthcare Capital Partners III,...

Exchange Agreements

Applied Therapeutics Inc.

2023

Convertible Notes Exchange Agreement for Common Stock and Warrants, dated September 18, 2023, by and among, the Company, Athyrium Opportunities III Acquisition LP and Athyrium...

Exchange Agreements

PROGENITY, INC.

2023

Cancellation and Exchange Agreement between Marizyme, Inc. and Frank Maresca, dated as of August 30, 2023

Exchange Agreements

MARIZYME INC

2023

Deferred Expense Exchange Agreement between the Registrant and TheraCour effective July 19, 2023

Exchange Agreements

NANOVIRICIDES, INC.

2023

Form of Exchange Agreement

Exchange Agreements

Invitae Corp

2023

Exchange Agreement, dated July 21, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited

Exchange Agreements

AgeX Therapeutics, Inc.

2023

Form of Exchange Agreement dated as of July 18, 2023 between the Company and the holder of the Exchange Securities

Exchange Agreements

Kiromic Biopharma, Inc.

2023

Share Exchange Agreement between BioNexus and Chemrex

Exchange Agreements

BioNexus Gene Lab Coporation

2023

Stock Exchange Agreement dated as of June 1, 2023 between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr

Exchange Agreements

NAVIDEA BIOPHARMACEUTICALS, INC.

2023

Cancellation and Exchange Agreement between Marizyme, Inc. and Frank Maresca, dated as of May 30, 2023

Exchange Agreements

MARIZYME INC

2023

Cancellation and Exchange Agreement between Marizyme, Inc. and Walleye Opportunities Master Fund Ltd, dated as of May 30, 2023

Exchange Agreements

MARIZYME INC

2023

Cancellation and Exchange Agreement between Marizyme, Inc. and Hexin Global Ltd., dated as of May 30, 2023

Exchange Agreements

MARIZYME INC

2023

Category

Industry

Companies

Contracts

Exchange Agreements in the Biotechnology Industry